Palisade Bio (PALI)

• Market cap: $310M
• 1 day: 13.66%
• 5 days: 16.85%
• 1 month: -8.77%
• 3 months: 227.61%
• 6 months: 196.55%
• Year to date: 11.83%
• 1 year: 18.86%
• 5 years: -99.94%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Employees: 8